onlyTrustedInfo.comonlyTrustedInfo.comonlyTrustedInfo.com
Notification
Font ResizerAa
  • News
  • Finance
  • Sports
  • Life
  • Entertainment
  • Tech
Reading: Novo Nordisk ends Wegovy sales on Hims & Hers over “deceptive marketing”
Share
onlyTrustedInfo.comonlyTrustedInfo.com
Font ResizerAa
  • News
  • Finance
  • Sports
  • Life
  • Entertainment
  • Tech
Search
  • News
  • Finance
  • Sports
  • Life
  • Entertainment
  • Tech
  • Advertise
  • Advertise
© 2025 OnlyTrustedInfo.com . All Rights Reserved.
Life

Novo Nordisk ends Wegovy sales on Hims & Hers over “deceptive marketing”

Last updated: June 24, 2025 9:25 pm
Oliver James
Share
4 Min Read
Novo Nordisk ends Wegovy sales on Hims & Hers over “deceptive marketing”
SHARE

Novo Nordisk is pulling the plug on its partnership with Hims & Hers Health over claims that the telehealth company sold fake versions of the pharmaceutical firm’s weight-loss drug, Wegovy.

The Danish drugmaker said Monday that Wegovy will no longer be available on Hims & Hers and that it is ending the collaboration because the San Francisco-based online health company sold “illegitimate, knockoff versions of Wegovy that put patient safety at risk.”

Novo Nordisk’s move to dissolve the partnership came less than two months after the companies said they were entering a “long-term collaboration” to make obesity treatment more accessible.

Shares of Hims & Hers plunged more than $20, or roughly 31%, to $44.10 following Novo Nordisk’s announcement.

Hims & Hers did not immediately respond to a request for comment. The company had expected to make more than $700 million this year on weight-loss services, a target that could be difficult to reach without Wegovy sales.

Novo Nordisk said it began selling Wegovy via telehealth companies, including Hims & Hers, after a nationwide shortage. In offering the drug through more retailers, Novo Nordisk said it wanted to shift patients from using “knock-off, compounded versions” of Wegovy to the Food and Drug Administration-approved semaglutide drug.

This followed an order from the FDA that sought to restrict compounding pharmacies from selling copycat weight-loss drugs, a move that’s expected to drive up prices.

“After over one month into the collaboration, Hims & Hers Health, Inc. has failed to adhere to the law which prohibits mass sales of compounded drugs under the false guise of ‘personalization’ and are disseminating deceptive marketing that put patient safety at risk,” a Novo Nordisk spokesperson told CBS MoneyWatch. “This is unacceptable, and that is why we have decided to end the collaboration.”

The FDA approved Wegovy for adults with obesity in March 2024, adding it to an expanding market of weight-loss drugs that include Ozempic and Mounjaro. Demand for GLP-1 drugs, which are used to treat diabetes and weight loss, has surged in recent years, with one in eight U.S. adults saying they’ve used the treatments, according to health research publisher KFF.

In its release, Novo Nordisk said a company investigation showed that the ingredients in knock-off drugs sold by telehealth entities and compounding pharmacies are manufactured by foreign suppliers in China and that a large share of the drugs were never inspected by the FDA.

“U.S. patients should not be exposed to knock-off drugs made with unsafe and illicit foreign ingredients,” Novo Nordisk said.

Novo Nordisk will continue to sell Wegovy on other telehealth platforms that “share our commitment to patient safety,” said Dave Moore, executive vice president at Novo Nordisk, in the company’s statement. Among the telehealth companies Novo Nordisk partners with are LifeMD and Ro.

Kidney dialysis industry accused of maximizing profits over patients

Extended interview: LQ Goldring on her quest for a kidney donor

Private insurers are working to ease the prior authorization process. Here’s what that means.

You Might Also Like

Emgality Explained: Usage, Dosage, And Side Effects

How I Get Dressed: WNBA Player Satou Sabally

If I’m Single…Am I My Own Emergency Contact? Here’s the Answer

Alzheimer’s Symptoms May Surface in Your 20s, Study Finds

Multivitamins can be helpful for anyone. But which ones are best for women?

Share This Article
Facebook X Copy Link Print
Share
Previous Article Feeling the Heat? Know These Signs and Symptoms of Heat Stroke Feeling the Heat? Know These Signs and Symptoms of Heat Stroke
Next Article China plans to show off new equipment at parade marking 80th anniversary of Japan’s WWII surrender China plans to show off new equipment at parade marking 80th anniversary of Japan’s WWII surrender

Latest News

Ukraine’s ambassador to US departing as Zelensky shakes up diplomats
Ukraine’s ambassador to US departing as Zelensky shakes up diplomats
News July 9, 2025
Trump taps Sean Duffy as interim NASA administrator
Trump taps Sean Duffy as interim NASA administrator
News July 9, 2025
Tillis suggests he wouldn’t vote in favor of Hegseth confirmation now
Tillis suggests he wouldn’t vote in favor of Hegseth confirmation now
News July 9, 2025
‘He’s Abusing The Public Trust’: Halperin Tells Megyn Kelly What Press Won’t Admit About Biden’s Doctor
‘He’s Abusing The Public Trust’: Halperin Tells Megyn Kelly What Press Won’t Admit About Biden’s Doctor
News July 9, 2025
//
  • About Us
  • Contact US
  • Privacy Policy
onlyTrustedInfo.comonlyTrustedInfo.com
© 2025 OnlyTrustedInfo.com . All Rights Reserved.